Form 4: Edwards Lifesciences Director Loranger Exercises Options and Sells Shares
SEC Filing
Director Steven R. Loranger of Edwards Lifesciences Corp. exercised stock options and sold shares on February 14, 2025, according to a Form 4 filing with the SEC.
Summary
- On February 14, 2025, Steven R. Loranger, a director at Edwards Lifesciences Corp., exercised stock options to acquire 5,739 shares of common stock at a price of $45.3167 per share.
- Simultaneously, Loranger sold 5,739 shares of common stock at a weighted average price of $76.4202, with prices ranging from $76.400 to $76.435.
- Following these transactions, Loranger directly owns 60,372 shares of Edwards Lifesciences common stock and indirectly owns 15,000 shares through a trust.
Sentiment
Score: 5
Explanation: The sentiment is neutral as it simply reports transactions. It doesn't indicate positive or negative outlook for the company.
Industry Context
This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. These transactions can be influenced by various factors, including personal financial planning and the director's view of the company's future prospects.
Stakeholder Impact
- The transactions may have a minor impact on shareholders due to the change in ownership, but the effect is likely minimal given the relatively small number of shares involved.
Key Dates
| Date | Description |
|---|---|
| 05/18/2018 | Date Director Stock Option (Right to Acquire) was granted |
| 02/14/2025 | Date of transaction: exercise of stock options and sale of shares. |
| 05/17/2025 | Expiration date of Director Stock Option (Right to Acquire) |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.